Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anker SC"'
Autor:
Gwenzi T; German Cancer Research Center (DKFZ) Heidelberg, Division of Preventive Oncology, Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Schrotz-King P; German Cancer Research Center (DKFZ) Heidelberg, Division of Preventive Oncology, Heidelberg, Germany., Anker SC; Department of Internal Medicine and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany., Schöttker B; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Network Aging Research, Heidelberg University, Heidelberg, Germany., Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brenner H; German Cancer Research Center (DKFZ) Heidelberg, Division of Preventive Oncology, Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de.; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de.; Network Aging Research, Heidelberg University, Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@Dkfz-Heidelberg.de.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Oct; Vol. 131 (7), pp. 1195-1201. Date of Electronic Publication: 2024 Aug 27.
Autor:
Gwenzi T; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg; Medical Faculty Heidelberg, Heidelberg University, Heidelberg., Schrotz-King P; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg., Anker SC; Department of Internal Medicine, University Hospital Heidelberg, Heidelberg., Schöttker B; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg; Network Aging Research, Heidelberg University, Heidelberg., Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg., Brenner H; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg; Network Aging Research, Heidelberg University, Heidelberg; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: h.brenner@Dkfz-Heidelberg.de.
Publikováno v:
ESMO open [ESMO Open] 2024 Apr; Vol. 9 (4), pp. 102982. Date of Electronic Publication: 2024 Apr 12.
Autor:
Anker SC; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Department of Internal Medicine I and Clinical Chemistry, Heidelberg University Hospital, Im Neuenheimer Feld 671, 69120 Heidelberg, Germany., Szczeponik MG; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Medical School, Heidelberg University, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany., Dessila J; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Dittus K; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Im Neuenheimer Feld 234, 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Engeland CE; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Center for Biomedical Research and Education (ZBAF), Institute of Virology and Microbiology, Faculty of Health, School of Medicine, Witten/Herdecke University, Stockumer Straße 10, 58453 Witten, Germany., Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Ungerechts G; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada., Leber MF; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
Publikováno v:
Viruses [Viruses] 2023 Jan 22; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 22.
Autor:
Anker SC; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany., Morgenstern J; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany., Adler J; Medical Laboratory for Clinical Chemistry, Microbiology, Infectious Diseases and Genetics Prof. Schenk/Dr. Ansorge & Colleagues, Magdeburg, Germany., Brune M; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany., Brings S; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany.; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Fleming T; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany., Kliemank E; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany., Zorn M; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany., Fischer A; Institute of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.; Division Vascular Signaling and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Szendroedi J; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany., Kihm L; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany., Zemva J; Department of Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Publikováno v:
Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2022 Dec 20; Vol. 61 (3), pp. 452-463. Date of Electronic Publication: 2022 Dec 20 (Print Publication: 2023).
Autor:
Leber MF; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Baertsch MA; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany., Anker SC; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany., Henkel L; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Singh HM; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Bossow S; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada., Engeland CE; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Barkley R; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada., Hoyler B; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Albert J; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., von Kalle C; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany., Ungerechts G; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DFKZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2018 Apr 12; Vol. 9, pp. 30-40. Date of Electronic Publication: 2018 Apr 12 (Print Publication: 2018).